Systematic Review
Published on 09 Nov 2023
Endocrine-disrupting chemicals and breast cancer: a meta-analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1282651
- 4,025 views
- 10 citations
- Frontiers in Oncology
- Breast Cancer
- Articles
Type at least 3 characters
1,293 articles
Articles
Original Research
Published on 07 Nov 2023
Immune responses and clinical outcomes following the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in advanced breast cancer patients receiving targeted therapies: a prospective study
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1280416
- 1,829 views
- 2 citations
Original Research
Published on 07 Nov 2023
Prognostic value analysis of cholesterol and cholesterol homeostasis related genes in breast cancer by Mendelian randomization and multi-omics machine learning
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1246880
- 5,311 views
- 2 citations
Original Research
Published on 06 Nov 2023
Locally advanced breast cancer: breast-conserving surgery and other factors linked to overall survival after neoadjuvant treatment
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1293288
- 2,047 views
- 2 citations
Original Research
Published on 06 Nov 2023
Subpopulation treatment effect pattern plot analysis: a prognostic model for distant recurrence-free survival to estimate delayed adjuvant chemotherapy initiation effect in triple-negative breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1193927
- 1,880 views
Original Research
Published on 02 Nov 2023
Influence of sarcopenia on postoperative complications in patients undergoing autologous microsurgical breast reconstruction: an inverse probability of treatment weighting analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1211593
- 1,350 views
- 1 citation
Original Research
Published on 30 Oct 2023
Maximum intensity projection based on high frame rate contrast-enhanced ultrasound for the differentiation of breast tumors
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1274716
- 1,338 views
- 2 citations
General Commentary
Published on 30 Oct 2023
Response: Commentary: Human gut, breast, and oral microbiome in breast cancer: A systematic review and meta-analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1279862
- 1,014 views
- 1 citation
Case Report
Published on 30 Oct 2023
Acrofacial vitiligo secondary to PI3KCA inhibitor, alpelisib: case report
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1255832
- 1,410 views
- 1 citation
Original Research
Published on 26 Oct 2023
Late onset toxicities associated with the use of CDK 4/6 inhibitors in hormone receptor positive (HR+), human epidermal growth factor receptor-2 negative (HER2-) metastatic breast cancer patients: a multidisciplinary, pan-EU position paper regarding their optimal management. The GIOCONDA project
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1247270
- 7,378 views
- 4 citations
Systematic Review
Published on 25 Oct 2023
Capecitabine-based chemotherapy in early-stage triple-negative breast cancer: a meta-analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1245650
- 3,412 views
Review
Published on 24 Oct 2023
Circulating tumor biomarkers in early-stage breast cancer: characteristics, detection, and clinical developments
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1288077
- 3,559 views
- 7 citations
Original Research
Published on 24 Oct 2023
Construction and validation of a nomogram for predicting the prognosis of patients with lymph node-positive invasive micropapillary carcinoma of the breast: based on SEER database and external validation cohort
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1231302
- 2,184 views
- 3 citations
Case Report
Published on 24 Oct 2023
Case Report: Bilateral targeted intraoperative radiotherapy: a safe and effective alternative for synchronous bilateral breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1276766
- 1,566 views
- 2 citations
Original Research
Published on 24 Oct 2023
Longitudinal dynamic contrast-enhanced MRI radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1264259
- 2,847 views
- 4 citations
Review
Published on 24 Oct 2023
Decoding TROP2 in breast cancer: significance, clinical implications, and therapeutic advancements
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1292211
- 6,686 views
- 7 citations